Figures computed from official regulatory filings — .
Analysttarget 30 USD (+914%) · consensus 5/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 29.53% · institutions 2.18% · short 2.0% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Ernexa Therapeutics Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Ernexa Therapeutics Inc., a preclinical-stage company, develops induces derived mesenchymal stem cells (iMSC) therapies for the treatment of treatment of cancer and autoimmune disease. The company's lead product is ERNA-101, an allogenic pro-inflammatory cytokine (IL-7/IL-15) secreting iMSC for the treatment of ovarian cancer; and ERNA-201, an anti-inflammatory cytokine (IL-10) secreting iMSC for the treatment of rheumatoid arthritis. It has a license agreement with Factor Bioscience Limited. The company was formerly known as Eterna Therapeutics Inc. and changed its name to Ernexa Therapeutics in March 2025. Ernexa Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
260 buys64 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Cicala Peter | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Luther Sanjeev | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Bristol James Arthur | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Wexler William A. | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Bristol James Arthur | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Polinsky David | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cicala Peter | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Ratner Elena | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cherington Charlestrack record | Buy | $2M | conv 58 | SEC |
| Cherington Charlestrack record | BuyD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Gurrola Sandra M | Exercise | n/a (No price was disclosed in the filing) | SEC |
| Gurrola Sandra M | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cherington Charlestrack record | Buy | $2.1M | conv 55 | SEC |
| Cherington Charlestrack record | Buy | n/a (No price was disclosed in the filing) | conv 76 | SEC |
| Cherington Charlestrack record | Buy | n/a (No price was disclosed in the filing) | conv 51 | SEC |
| Cherington Charlestrack record | Buy | n/a (No price was disclosed in the filing) | conv 62 | SEC |
| Cherington Charlestrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Cherington Charlestrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Cherington Charlestrack record | Buy | n/a (No price was disclosed in the filing) | conv 54 | SEC |
| Cherington Charlestrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Cherington Charlestrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Cherington Charlestrack record | Buy | n/a (No price was disclosed in the filing) | conv 71 | SEC |
| Cherington Charlestrack record | SellD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| Cherington Charlestrack record | Buy | $376.8K | conv 42 | SEC |
| Luther Sanjeev | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |